Genome-wide association meta-analysis and rare copy number variant analysis of treatment-resistant depression
Open Access
- 26 June 2025
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (11) , 5024-5033
Abstract
Treatment-resistant depression (TRD), defined as major depressive disorder (MDD) with multiple failed responses to antidepressant treatments, has been suggested to be heritable, but identifying its genetic component is challenging. Using a restrictive TRD definition based on antidepressant medication followed by electroconvulsive therapy (ECT), which may represent a severe subset of TRD cases, we investigated both common variants and rare copy number variations (CNVs) associated with a) TRD risk (2 062 TRD vs. 441 037 healthy controls) and b) treatment resistance in MDD (2 062 TRD vs. 38 544 non-TRD) across three Nordic countries. We observed a significant SNP-based heritability for TRD risk at 26% (SE = 5%). Genome-wide association analysis identified one locus on chromosome 3 (intronic region of SPATA16) for TRD risk and one suggestive locus for treatment resistance in MDD. TRD risk showed positive genetic correlations (r g ) with other psychiatric disorders, with notably r g with bipolar disorder (0.86, SE = 0.20) and schizophrenia (0.57, SE = 0.13), as well as a negative r g with intelligence (−0.13, SE = 0.07). Analyses using PRS showed that TRD had higher common-variant burdens of various psychiatric disorders compared to non-TRD. Furthermore, TRD carried a higher CNV deletion burden in total and average lengths than healthy controls or non-TRD cases and was associated with a group of 54 known neuropsychiatric CNVs (ORs = 1.74–2.86). Given that our definition of TRD involves the use of ECT, our findings may reflect a severe form of treatment resistance. This work adds evidence on a genetic basis and provides insights into the genetic architecture of TRD, underscoring the need for further genomic research into this ‘difficult-to-treat’ condition.Keywords
Funding Information
- Forskningsrådet för hälsa, arbetsliv och välfärd (2021-00132)
This publication has 80 references indexed in Scilit:
- Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide StudyJAMA Psychiatry, 2023
- Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in SchizophreniaJAMA Psychiatry, 2022
- The Growing Burden of Major Depressive Disorders (MDD): Implications for Researchers and Policy MakersPharmacoEconomics, 2021
- International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic)European Archives of Psychiatry and Clinical Neuroscience, 2019
- Defining treatment‐resistant depressionDepression and Anxiety, 2019
- Association of Rare Copy Number Variants With Risk of DepressionJAMA Psychiatry, 2019
- Toward an Evidence-Based, Operational Definition of Treatment-Resistant DepressionJAMA Psychiatry, 2017
- Analysis of Intellectual Disability Copy Number Variants for Association With SchizophreniaJAMA Psychiatry, 2016
- Association between copy number variants in 16p11.2 and major depressive disorder in a German case–control sampleAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2012
- GCTA: A Tool for Genome-wide Complex Trait AnalysisThe American Journal of Human Genetics, 2011